Therapeutic Targets in Chronic Lymphocytic Leukemia

被引：3
|
作者：
Laurenti, Luca [1 ]
Efremov, Dimitar G. [2 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Hematol, I-00168 Rome, Italy
[2] Int Ctr Genet Engn & Biotechnol, Mol Hematol, I-34149 Trieste, Italy
来源：
CANCERS | 2020年 / 12卷 / 11期
关键词：
IBRUTINIB RESISTANCE; CLONAL EVOLUTION; DE-NOVO; VENETOCLAX; CLL; DISEASE; BTK; INHIBITION;
D O I：
10.3390/cancers12113259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] PHOSPHOPROTEOMIC ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA AND B-CELL RECEPTOR SIGNALING SUGGESTS NOVEL THERAPEUTIC TARGETS
    Butler, T.
    Taussig, D.
    Cutillas, P.
    Gribben, J.
    HAEMATOLOGICA, 2012, 97 : 49 - 49
  • [32] NADPH Oxidases as Therapeutic Targets in Chronic Myelogenous Leukemia
    Sanchez-Sanchez, Beatriz
    Gutierrez-Herrero, Sara
    Lopez-Ruano, Guillermo
    Prieto-Bermejo, Rodrigo
    Romo-Gonzalez, Marta
    Llanillo, Marcial
    Pandiella, Atanasio
    Guerrero, Carmen
    San Miguel, Jesus F.
    Sanchez-Guijo, Fermin
    del Canizo, Consuelo
    Hernandez-Hernandez, Angel
    CLINICAL CANCER RESEARCH, 2014, 20 (15) : 4014 - 4025
  • [33] Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
    Anoop, Parameswaran
    Patil, Channappa N.
    Sandhya, Venkatachalam
    Dhande, Sonal
    Janardan, Kalpana
    Ahlawat, Shivali
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2018, 39 (04) : 557 - 558
  • [34] Concurrent hairy cell leukemia and chronic lymphocytic leukemia: Diagnostic and therapeutic implications
    Anoop, Parameswaran
    Patil, Channappa N.
    Sandhya, Venkatachalam
    Dhande, Sonal
    Janardan, Kalpana
    Ahlawat, Shivali
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (04) : 624 - 624
  • [35] Concurrent Hairy Cell Leukemia and Chronic Lymphocytic Leukemia: Diagnostic and Therapeutic Implications
    Al-Mendalawi, Mahmood Dhahir
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (01) : 102 - 102
  • [36] Immunoproteomic identification of graft-versus-leukemia targets in patients with chronic lymphocytic leukemia
    Marina, Ovidiu
    Biemacki, Melinda
    Cai, Ann
    Zhang, Wandi
    Duke-Cohan, Jonathan S.
    Brusic, Vladimir
    Liu, Fenglong
    Alyea, Edwin
    Canning, Christine M.
    Seiffer, Robert
    Ritz, Jerome
    Wu, Catherine J.
    BLOOD, 2007, 110 (11) : 30A - 30A
  • [37] Therapeutic potential of antagonizing BLyS for chronic lymphocytic leukemia.
    Zhou, T
    Liu, WM
    Zhao, LM
    Carter, RH
    Kimberly, RP
    Emanuel, PD
    BLOOD, 2001, 98 (11) : 808A - 808A
  • [38] NF-κB as a therapeutic target in chronic lymphocytic leukemia
    Lopez-Guerra, Monica
    Colomer, Dolors
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2010, 14 (03) : 275 - 288
  • [39] Casein kinase 1 is a therapeutic target in chronic lymphocytic leukemia
    Janovska, Pavlina
    Verner, Jan
    Kohoutek, Jiri
    Bryjova, Lenka
    Gregorova, Michaela
    Dzimkova, Marta
    Skabrahova, Hana
    Radaszkiewicz, Tomasz
    Ovesna, Petra
    Blanarova, Olga Vondalova
    Nemcova, Tereza
    Hoferova, Zuzana
    Vasickova, Katerina
    Smyckova, Lucie
    Egle, Alexander
    Pavlova, Sarka
    Poppova, Lucie
    Plevova, Karla
    Pospisilova, Sarka
    Bryja, Vitezslav
    BLOOD, 2018, 131 (11) : 1206 - 1218
  • [40] Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia
    Khurana, Sharad
    Ahmed, Salman
    Alegria, Victoria R.
    Aulakh, Sonikpreet
    Ailawadhi, Meghna
    Singh, Anshika
    Chanan-Khan, Asher
    Ailawadhi, Sikander
    SAGE OPEN MEDICAL CASE REPORTS, 2019, 7
12345